使用益生菌酵母进行现场生物制造的技术.
William Parker1, Amanda Taylor1, Aryan Razdan1
1Department of Chemical Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Advanced drug delivery reviews
|May 18, 2025
概括
萨卡罗米塞斯·布拉迪 (Sb) 是一个有前途的益生菌工程平台. 研究正在推进治疗胃肠道疾病的遗传工具和肠道特异性应用.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 胃肠病学 胃肠病学
背景情况:
- 糖菌 (Saccharomyces boulardii) (Sb) 是一种用于减轻胃肠道症状的GRAS益生菌酵母.
- 与细菌益生菌相比,Sb具有独特的优势,包括对菌体的耐药性和高蛋白质分泌.
- 对Saccharomyces cerevisiae (Sc) 的基因工程工具正在适应Sb.
研究的目的:
- 为了回顾工程学Saccharomyces boulardii的最新进展.
- 为突出研究基因工程,殖民调制,生物标记物传感和Sb.药物生产的研究.
- 讨论克服工程化Sb性能的肠道特异性挑战.
主要方法:
- 关于Saccharomyces boulardii基因工程的当前文献的审查.
- 对益生菌和生物治疗开发的工具和策略的分析.
- 专注于研究解决工程化真核生物益生菌方面的挑战.
主要成果:
- 对Sb的基因工程工具的开发正在进展中.
- 调节Sb殖民和感知生物标志物的策略正在出现.
- Sb正在被推进为生物治疗的可扩展平台.
结论:
- 工程化Saccharomyces boulardii为新的胃肠道疾病治疗提供了一个可扩展的平台.
- 克服肠道特异性挑战是实现工程化Sb的全部潜力的关键.
- Sb的真核性质为生物治疗应用提供了明显的优势.
相关概念视频
01:29Microbes in Food Production
Microbial fermentation is central to food biotechnology, enhancing flavor, texture, preservation, and stability. Fermentative microorganisms metabolize carbohydrates into organic acids, alcohols, and other metabolites that inhibit spoilage organisms and improve digestibility while contributing distinctive sensory qualities.In baking, amylases naturally present in flour hydrolyze starch into monosaccharides such as glucose, which Saccharomyces cerevisiae ferments anaerobically. Through...
01:27Microbes in the Production of Fermented Foods
Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
01:29Bioreactor Design and Operational System
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:14Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...